Seed Health
Venice, US · Founded 2017 · Delaware corporation · 254 employees on LinkedIn · 23 known investors
Find your way into Seed Health
44 people in our graph can introduce you to the Seed Health team.
Sign up to see every warm intro you have to Seed Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seed Health team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Seed develops clinically studied probiotic and prebiotic formulations designed to support digestive health and overall wellness through proprietary delivery technology that protects beneficial bacteria through the digestive tract.
Also known as Seed · Seed Health, Inc.
Founders & leadership
Seed Health was founded in 2017 by Ara Katz and Rajat Dhir.

Investors · 23
How we know: av.vc · Not right? Tell us
How we know: Artis Ventures's portfolio page · finance.yahoo.com · Not right? Tell us
How we know: Bold Capital Partners's portfolio page · Not right? Tell us
How we know: Collaborative Fund's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Cota Capital's portfolio page · Not right? Tell us
How we know: Grant Park Ventures's portfolio page · Not right? Tell us
How we know: Greycroft's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Kicker Ventures's portfolio page · Not right? Tell us
How we know: M13's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: MaC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: The Chernin Group (TCG Crypto)'s portfolio page · the VCSheet dataset · Not right? Tell us
How we know: finance.yahoo.com · Not right? Tell us
How we know: Valia Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$80.6M disclosed across 2 rounds · 2021
- $40MSeries AApr 2021 · 3 sources
The Craftory (lead), 8VC, ARTIS Ventures, Founders Fund, GISEV
Source ↗
▶$40.6MraisedApr 2021 · 60 investors · Other TechnologyRule 506(b)
- Ara KatzExecutive Officer, Director
- Andy BradleyExecutive Officer
- Rajat DhirExecutive Officer, Director
- Offering amount
- $40.6M
- Amount sold
- $40.6M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Seed Health is a microbial sciences company that develops applications of bacteria for human and environmental health. Working with academic partners, it translates research into live biotherapeutics and consumer health innovations, with a pipeline described as covering interventions for infectious disease, allergy, and inflammatory conditions across various body sites and windows of development. Its consumer probiotic products are commercialized under the Seed brand.
The consumer line is anchored by DS-01 Daily Synbiotic, a two-in-one capsule product using ViaCap technology in which an outer capsule shields the probiotics from stomach acid and delivers prebiotics while the inner capsule releases 24 live probiotic strains in the colon. The company has expanded beyond the synbiotic into a broader daily supplement range including DM-02 Daily Multivitamin, AM-02 Energy + Focus, and PM-02 Sleep + Restore, along with bundled daily-essentials offerings. Seed also runs a research arm, Seed Labs, focused on non-human/environmental applications of microbial science, and maintains consumer education content under a "Microbiome 101" science section.
Seed Health conducts human clinical research on its formulations, including trials of DS-01 in irritable bowel syndrome, constipation, and post-antibiotic contexts; a Phase II randomized, triple-blind, placebo-controlled trial investigating the gut microbiome in IBS patients has been run at Beth Israel Deaconess Medical Center. In 2019 it organized a community science initiative, #GiveAShit, which assembled a large stool image bank and was recognized in Fast Company's 2020 World Changing Ideas.
Business model
Direct-to-consumer sale of probiotic and supplement products on a monthly subscription basis, with published prices starting at $49.99 per month for DS-01 Daily Synbiotic, $39.99 for DM-02 Daily Multivitamin, and $34.99 each for AM-02 Energy + Focus and PM-02 Sleep + Restore, plus discounted multi-product bundles.
Recurring monthly subscription revenue from consumer supplement formulations sold under the Seed brand.
Traction
The company's website cites over one million health transformations from its products. Its 2019 #GiveAShit community science initiative assembled what was described as the largest bank of stool imagery to date and won Fast Company's 2020 World Changing Ideas award.
Latest developments
Recent company announcements include new data indicating its Co-Biotic formulations modulate the gut microbiome, increasing bioactive vitamin B3, gut-brain metabolites, and sleep-related tryptophan, and the appointment of Anisha Raghavan as the company's first chief marketing officer.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positions itself as a microbiome science company combining consumer probiotic products with clinical research and academic collaborations rather than as a conventional supplement brand.
Emphasis on clinically studied ingredients, a capsule technology designed for survival through digestion, in-house and partnered clinical trials, and ownership of AI-based digestive health measurement technology acquired from Auggi.
Technology
Seed's DS-01 uses a ViaCap nested-capsule delivery system: an outer capsule protects probiotics from stomach acid and carries prebiotics, while an inner capsule delivers 24 live probiotic strains to the colon. Through its acquisition of Auggi, the company added deep learning technology for automated stool image detection and consistency characterization, using computer vision and deep convolutional neural networks trained against the Bristol Stool Chart benchmark, reported at 94.07% accuracy in predicting the correct Bristol class within one level versus about 75% for self-assessment, along with a mobile monitoring application used in clinical research.
Go-to-market
Online direct-to-consumer sales via the company's website, supported by a product recommendation quiz, subscription pricing, customer testimonials, and science-education content; credibility is also built through academic collaborations and clinical trials.
Consumers seeking gut, digestive, energy, sleep, and general nutritional support; clinical research participants and investigators are engaged through the company's trial programs.
Geography
Announcements are issued from Los Angeles; clinical research collaborations referenced include Massachusetts General Hospital and Beth Israel Deaconess Medical Center in the United States.
History
Seed Health was co-founded by Ara Katz, who serves as co-CEO. In 2019 the company ran the #GiveAShit community science initiative to build a stool image database, and in February 2021 it acquired the technology assets of digital health company Auggi, subsequently integrating Auggi's mobile tracking application into its clinical trials and planning a consumer-facing digital product built on the AI and stool database for 2021.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
2 people who came through Seed Health went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Seed Health.
Timeline · 4
launches, deals, and filingsSeed Health announced the appointment of Anisha Raghavan as its first-ever chief marketing officer.
Seed Health presented data indicating its Co-Biotic formulations modulate the gut microbiome, increasing bioactive vitamin B3, gut-brain metabolites, and sleep-related tryptophan.
Seed Health announced the acquisition of Auggi's technology assets, including an AI algorithm for real-time Bristol stool typing, a large stool image database, and a mobile monitoring application for clinical research. Auggi was founded by David Hachuel and Alfonso Martinez.
Seed's 2019 #GiveAShit community science initiative, which amassed the stool imagery bank used to train Auggi's algorithms, was named a winner of Fast Company's 2020 World Changing Ideas.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 2
primary sources listed
- Seed Health exitedseedhealth.com · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Seed Health do?
- Microbiome science company selling clinically studied probiotic and supplement formulations under the Seed brand.
- Who founded Seed Health?
- Seed Health was founded by Ara Katz, Rajat Dhir in 2017.
- Who are Seed Health's investors?
- Seed Health's investors include Alumni Ventures, Artis Ventures, Bold Capital Partners, BoxGroup, Collaborative Fund, Color Capital, Cota Capital, Grant Park Ventures and 14 more.
- How much funding has Seed Health raised?
- Seed Health has disclosed $80.6M raised across 2 rounds.
- Where is Seed Health headquartered?
- Seed Health is headquartered in Venice, US.















